DoH Policies screened during the period: 1st October 2016 to 31st December 2016

In fulfilling its obligations under Section 75 the Department is required to equality screen all of its policies and services under consideration to determine whether they should be subject to a full equality impact assessment (EQIA).

Documents

NICE Technology Appraisal - TA407 - Secukinumab for treating ankylosing spondylitis after inadequate response to non-steroidal anti-inflammatory drugs or TNF-alpha inhibitors
PDF (153 KB)

NICE Technology Appraisal TA412 - Radium-223 dichloride for treating hormone-relapsed prostate cancer with bone metastases
PDF (176 KB)

NICE Technology Appraisal TA410 - Talimogene laherparepvec for treating unresectable metastatic melanoma
PDF (155 KB)

NICE Technology Appraisal TA409 - Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion
PDF (153 KB)

NICE Technology Appraisal - TA 406 - Crizotinib for untreated anaplastic lymphoma kinase-positive non-small-cell lung cancer
PDF (153 KB)

NICE Technology Appraisal TA408 - Pegaspargase for treating acute lymphoblastic leukaemia
PDF (149 KB)

NICE Technology Appraisal TA411 - Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer
PDF (152 KB)

NICE Clinical Guideline - NG54 - Mental health problems in people with learning disabilities: prevention, assessment and management
PDF (156 KB)

NICE Public Health Guideline NG48 - Oral health for adults in care homes
PDF (156 KB)

NICE Clinical Guideline - NG56 - Multimorbidity: clinical assessment and management
PDF (154 KB)

NICE Technology Appraisal TA415 - Certolizumab pegol for treating rheumatoid arthritis after inadequate response to a TNF-alpha inhibitor
PDF (175 KB)

NICE Technology Appraisal TA414 - Cobimetinib in combination with vemurafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma
PDF (150 KB)

NICE Technology Appraisal TA413 Elbasvir–grazoprevir for treating chronic hepatitis C
PDF (157 KB)

NG26 - Children’s attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care
PDF (162 KB)

NICE Technology Appraisal TA418 - Dapagliflozin in triple therapy for treating type 2 diabetes (part review of TA288)
PDF (152 KB)

NICE Technology Appraisal TA417 - Nivolumab for treated or metastatic renal cell carcinoma
PDF (151 KB)

NICE Technology Appraisal TA419 - Apremilast for treating moderate to severe plaque psoriasis (review of TA368)
PDF (179 KB)

NICE Technology Appraisal TA420 - Ticagrelor for secondary prevention of atherothrombotic events after myocardial infarction
PDF (154 KB)

“The Right Time, The Right Place”: An expert examination of the application of health and social care governance arrangements for ensuring the quality of care provision in Northern Ireland
PDF (477 KB)

Criteria for Reconfiguring Health and Social Care Services
PDF (367 KB)

Help viewing documents